Here, we aimed to determine the therapeutic effect of longevity-associated variant (LAV)-BPIFB4 gene therapy on atherosclerosis.
Puca, A.a., Carrizzo, A., Spinelli, C., Damato, A., Ambrosio, M., Villa, F., et al. (2019). Single systemic transfer of a human gene associated with exceptional longevity halts the progression of atherosclerosis and inflammation in ApoE knockout mice through a CXCR4-mediated mechanism. EUROPEAN HEART JOURNAL, 41(26), 2487-2497 [10.1093/eurheartj/ehz459].
Single systemic transfer of a human gene associated with exceptional longevity halts the progression of atherosclerosis and inflammation in ApoE knockout mice through a CXCR4-mediated mechanism
Versaci, FrancescoSupervision
;
2019-07-10
Abstract
Here, we aimed to determine the therapeutic effect of longevity-associated variant (LAV)-BPIFB4 gene therapy on atherosclerosis.File in questo prodotto:
| File | Dimensione | Formato | |
|---|---|---|---|
|
Puca.pdf
solo utenti autorizzati
Descrizione: articolo principale
Licenza:
Copyright dell'editore
Dimensione
1.61 MB
Formato
Adobe PDF
|
1.61 MB | Adobe PDF | Visualizza/Apri Richiedi una copia |
I documenti in IRIS sono protetti da copyright e tutti i diritti sono riservati, salvo diversa indicazione.
